17 October 2022 in Cancer Letters
19 December 2024 in Journal of Cell Communication and Signaling
Chemo‐resistance in ovarian cancer is currently a major obstacle to the treatment and recovery of ovarian cancer. Therefore, identifying factors associated with chemo‐resistance in ovarian cancer may reverse chemo‐sensitization. Using isobaric tags for relative and absolute quantitation (ITRAQ) technology, we found a small molecule peptide with annexin 1 (ANXA1) as a precursor protein. Then, we explored the effects and mechanisms of this small molecule peptide on the proliferation, apoptosis, and drug resistance of ovarian cancer resistant cells through CCK‐8, EdU cell proliferation assay, Annexin V‐FITC/PI assay, Western blot,qRT‐PCR. ANXA114‐26 was highly expressed in the serums of sensitive patients. ANXA114‐26 promoted apoptosis of ovarian cancer cells and increased the sensitization of ovarian cancer cells to cisplatin. The ANXA114‐26 and ANXA1 competitively bind formyl peptide receptors (FPR). ANXA114‐26 decreased multidrug resistance‐associated protein 1 (MRP1) expression in ovarian cancer cells through the FPR/Cyclin D1/NF‐ĸBp65 pathway. We found a peptide derived named ANXA114‐26 in the serum of ovarian cancer patients. It can reduce ovarian cancer cell proliferation and reduce MRP1 expression through the FPR/Cyclin D1/NF‐ĸBp65 pathway.
13 April 2022 in Stem Cell Research & Therapy
16 June 2020 in Journal of Bio-X Research
Myosins comprise a large superfamily of adenosine triphosphatases (ATPases) that interact with actin filaments to generate motility or force. Unconventional myosins are implicated in diverse cellular processes including organelle trafficking, F-actin organization and cell movement. The unconventional myosin, myosin XVA (MYO15A), is localized at the tips of stereocilia in the inner ear hair cells and plays important roles in the development and maintenance of stereocilia. Mutations in MYO15A / Myo15a genes are responsible for hearing loss DFNB3 and shaker-2 in human and mice, respectively. In the present review, we will discuss the expression and alternative splicing of the MYO15A gene, the biochemical properties of the MYO15A protein and the association of MYO15A mutations with hearing loss. We will also discuss the recent investigations into the mechanism of how MYO15A regulates stereocilia development and maintenance. At present we are just beginning to appreciate the important roles of MYO15A in stereocilia, and further investigations are warranted to fully understand them.